Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity
Open Access
- 8 January 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 3 (1), 1035
- https://doi.org/10.1038/srep01035
Abstract
The expression of acid ceramidase (AC) – a cysteine amidase that hydrolyses the proapoptotic lipid ceramide – is abnormally high in several human tumors, which is suggestive of a role in chemoresistance. Available AC inhibitors lack, however, the potency and drug-likeness necessary to test this idea. Here we show that the antineoplastic drug carmofur, which is used in the clinic to treat colorectal cancers, is a potent AC inhibitor and that this property is essential to its anti-proliferative effects. Modifications in the chemical scaffold of carmofur yield new AC inhibitors that act synergistically with standard antitumoral drugs to prevent cancer cell proliferation. These findings identify AC as an unexpected target for carmofur, and suggest that this molecule can be used as starting point for the design of novel chemosensitizing agents.This publication has 37 references indexed in Scilit:
- The application of drug dose equivalence in the quantitative analysis of receptor occupation and drug combinationsPharmacology & Therapeutics, 2010
- The Acid Sphingomyelinase/Ceramide Pathway: Biomedical Significance and Mechanisms of RegulationCurrent Molecular Medicine, 2010
- An Overview of Sphingolipid Metabolism: From Synthesis to BreakdownAdvances in Experimental Medicine and Biology, 2010
- β‐Sitosterol enhances tamoxifen effectiveness on breast cancer cells by affecting ceramide metabolismMolecular Nutrition & Food Research, 2008
- The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenograftsThe Prostate, 2003
- Ceramide levels are inversely associated with malignant progression of human glial tumorsGlia, 2002
- [Anti-tumor effects of carmofur on human 5-FU resistant cells].1999
- (1S,2R)-D-erythro-2-(N-Myristoylamino)-1-phenyl-1-propanol as an Inhibitor of CeramidasePublished by Elsevier BV ,1996
- Antitumor Activity of Fluoropyrimidines and Thymidylate Synthetase InhibitionJapanese Journal of Cancer Research, 1991
- Antitumor activity of 1-hexylcarbamoyl-5-fluorouracil in a variety of experimental tumors.1976